A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Air pollution is a well-known risk factor for respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). However, its contribution to lower respiratory infections —those ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

A research team led by Professor Hajime Monzen and Dr. Hiroyuki Kosaka from the Department of Medical Physics at Kindai ...

Doctors from National Jewish Health talk about how to know if you’re at risk, and steps you can take to protect your heart ...

Nasal microbiota transplantation could revolutionise the treatment of chronic rhinosinusitis and respiratory tract infections ...